{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T09:40:52Z","timestamp":1648978852337},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,10]]},"DOI":"10.1093\/humrep\/16.10.2079","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T18:42:32Z","timestamp":1027708952000},"page":"2079-2083","source":"Crossref","is-referenced-by-count":3,"title":["Basal and day 12 inhibin concentrations in the prediction of ovarian response to gonadotrophins in women with PCOS"],"prefix":"10.1093","volume":"16","author":[{"given":"Devran","family":"Go\u0308kyar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arif","family":"Ko\u0308kc\u0327u\u0308","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filiz","family":"Yanik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet B.","family":"C\u0327etinkaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tayfun","family":"Alper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erdal","family":"Malatyaliog\u0306lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2001,10]]},"reference":[{"key":"key\n\t\t\t\t20170410040030_ANDERSON-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Anderson, R.A., Groome, N.P. and Baird, D.T. (1998) Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation. Clin. Endocrinology, 48, 577\u2013584.","DOI":"10.1046\/j.1365-2265.1998.00442.x"},{"key":"key\n\t\t\t\t20170410040030_BALASCH-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Balasch, J., Creus, M., Fabregues, F. et al. (1996) Inhibin, follicle-stimulating hormone, and age as predictors of ovarian response in in-vitro fertilization cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment. Am. J. Obstet. Gynecol., 175, 1226\u20131230.","DOI":"10.1016\/S0002-9378(96)70032-7"},{"key":"key\n\t\t\t\t20170410040030_BUCKLER-ETAL-1988","doi-asserted-by":"crossref","unstructured":"Buckler, H.M., McLachlan, R.I., MacLachlan, V.B. et al. (1988) Serum inhibin levels in polycystic ovary syndrome: basal levels and response to luteinizing hormone releasing hormone. Agonist and exogenous gonadotropin administration. J. Clin. Endocrinol. Metab., 66, 798\u2013803.","DOI":"10.1210\/jcem-66-4-798"},{"key":"key\n\t\t\t\t20170410040030_BUCKLER-ETAL-1989","doi-asserted-by":"crossref","unstructured":"Buckler, H.M., Healy, D.L. and Burger, H.G. (1989) Purified FSH stimulates production of inhibin by the human ovary. J. Endocrinology, 122, 279\u2013285.","DOI":"10.1677\/joe.0.1220279"},{"key":"key\n\t\t\t\t20170410040030_BUCKLER-ETAL-1992","doi-asserted-by":"crossref","unstructured":"Buckler, H.M., Robertson, W.R., Sun, J.G. and Morris, I.D. (1992) Immunoreactive inhibin levels during ovarian stimulation may predict granulosa cell maturity. Clin. Endocrinology, 37, 552\u2013557.","DOI":"10.1111\/j.1365-2265.1992.tb01487.x"},{"key":"key\n\t\t\t\t20170410040030_BURGER-1993","unstructured":"Burger, H.G. (1993) Clinical utility of inhibin measurements. J. Clin. Endocrinol. Metab., 76, 1391\u20131396."},{"key":"key\n\t\t\t\t20170410040030_DANFORTH-1995","doi-asserted-by":"crossref","unstructured":"Danforth, D.R. (1995) Endocrine and paracrine control of oocyte development. Am. J. Obstet. Gynecol., 172, 747\u2013752.","DOI":"10.1016\/0002-9378(95)90148-5"},{"key":"key\n\t\t\t\t20170410040030_ELDAR-GEVA-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Eldar-Geva, T., Robertson, D.M., Cahir, N. et al. (2000) Relationship between serum inhibin A and B and ovarian follicle development after a daily fixed dose administration of recombinant follicle-stimulating hormone. J. Clin. Endocrinol. Metab., 85, 607\u2013613.","DOI":"10.1210\/jc.85.2.607"},{"key":"key\n\t\t\t\t20170410040030_ERICKSON-AND-DANFORTH-1995","doi-asserted-by":"crossref","unstructured":"Erickson, G.F. and Danforth, D.R. (1995) Ovarian control of follicle development. Am. J. Obstet. Gynecol., 172, 736\u2013747.","DOI":"10.1016\/0002-9378(95)90147-7"},{"key":"key\n\t\t\t\t20170410040030_HAYES-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Hayes, F.J., Hall, J.E., Boepple, P.A. and Crowley, W.F. (1998) Differential control of gonadotropin secretion in the human: Endocrine role of inhibin. J. Clin. Endocrinol. Metab., 83, 1835\u20131841.","DOI":"10.1210\/jc.83.6.1835"},{"key":"key\n\t\t\t\t20170410040030_HILLIER-ETAL-1991","doi-asserted-by":"crossref","unstructured":"Hillier, S.G., Wickings, E.J., Illingworth, P.I. et al. (1991) Control of immunoreactive inhibin production by human granulosa cells. Clin. Endocrinology, 35, 71\u201378.","DOI":"10.1111\/j.1365-2265.1991.tb03499.x"},{"key":"key\n\t\t\t\t20170410040030_HOMBURG-AND-HOWLES-1999","doi-asserted-by":"crossref","unstructured":"Homburg. R. and Howles, C.M. (1999) Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements. Hum. Reprod. Update, 5, 493\u2013499.","DOI":"10.1093\/humupd\/5.5.493"},{"key":"key\n\t\t\t\t20170410040030_LOCKWOOD-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Lockwood, G.M., Muttukrshna, S., Groome, N.P. et al. (1996) Circulating inhibins and activin A during GNRH-analogue down-regulation and ovarian hyperstimulation with recombinant FSH for in vitro fertilisation-embryo transfer. Clin. Endocrinol. (Oxf.), 45, 741\u2013748.","DOI":"10.1046\/j.1365-2265.1996.8510861.x"},{"key":"key\n\t\t\t\t20170410040030_MATSON-ETAL-1991","doi-asserted-by":"crossref","unstructured":"Matson, P.L., Morris, I.D, Sun, J.G. et al. (1991) Serum inhibin as an index of ovarian function in women undergoing pituitary down-regulation and ovarian stimulation in an in-vitro fertilisation program. Horm. Res., 35, 173\u2013177.","DOI":"10.1159\/000181897"},{"key":"key\n\t\t\t\t20170410040030_MCLACHLAN-ETAL-1986","doi-asserted-by":"crossref","unstructured":"McLachlan, R.I., Robertson, D.M., Healy, D.L. et al. (1986) Plasma inhibin levels during gonadotropin induced ovarian hyperstimulation for IVF: A new index of follicular function. Lancet, i, 1233\u20131234.","DOI":"10.1016\/S0140-6736(86)91385-1"},{"key":"key\n\t\t\t\t20170410040030_PELLICER-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Pellicer, A., Mari, M., de los, Santos, M.J. et al. (1994) Effects of aging on the human ovary: the secretion of immunoreactive a-inhibin and progesterone. Fertil. Steril., 61, 663\u2013668.","DOI":"10.1097\/00006254-199409000-00022"},{"key":"key\n\t\t\t\t20170410040030_SCOTT-AND-HOFMANN-1995","doi-asserted-by":"crossref","unstructured":"Scott, Jr, R.T. and Hofmann, G.E. (1995) Prognostic assessment of ovarian reserve. Fertil. Steril., 63, 1\u201311.","DOI":"10.1016\/S0015-0282(16)57287-2"},{"key":"key\n\t\t\t\t20170410040030_SEIFER-ETAL-1993","doi-asserted-by":"crossref","unstructured":"Seifer, D.B., Charland, C., Berlinsky, D. et al. (1993) Proliferative index of human luteinized granulosa cells varies as a function of ovarian reserve. Am. J. Obstet. Gynecol., 169, 1531\u20131535.","DOI":"10.1016\/0002-9378(93)90430-Q"},{"key":"key\n\t\t\t\t20170410040030_SEIFER-ETAL-1996","unstructured":"Seifer, D.B., Gardiner, A.C., Lambert-Messerlian, G. and Schneyer A.L. (1996) Differential secretion of dimeric inhibin in cultured luteinized granulosa cells as a function of ovarian reserve. J. Clin. Endocrinol. Metab., 81, 736\u2013739."},{"key":"key\n\t\t\t\t20170410040030_SEIFER-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Seifer, D.B., Lambert-Messerlian, G., Hogan, J.W. et al. (1997) Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome. Fertil. Steril., 67, 11\u201315.","DOI":"10.1016\/S0015-0282(97)81865-1"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T03:13:25Z","timestamp":1497496405000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article-lookup\/doi\/10.1093\/humrep\/16.10.2079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":20,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2001,10]]},"published-print":{"date-parts":[[2001,10]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/16.10.2079","relation":{},"ISSN":["1460-2350","0268-1161"],"issn-type":[{"value":"1460-2350","type":"electronic"},{"value":"0268-1161","type":"print"}],"subject":[],"published":{"date-parts":[[2001,10]]}}}